(FDHT) Fidelity Covington Trust - - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Health
FDHT: Healthcare, Technology, Telemedicine, Robotics, Records, Devices
The Fidelity Covington Trust - Fidelity Digital Health ETF (BATS:FDHT) is a non-diversified exchange-traded fund (ETF) designed to track the performance of companies involved in technology-enabled healthcare solutions. The fund typically invests at least 80% of its assets in securities and depositary receipts included in its underlying index. This index focuses on a broad range of healthcare technology sectors, including but not limited to electronic health records (EHR), connected medical devices, surgical robotics, telemedicine platforms, and AI-driven healthcare tools. By targeting these areas, the ETF aims to capture growth opportunities in the rapidly evolving digital health landscape.
From a technical perspective, FDHT has shown recent price weakness, trading below its 20-day and 50-day simple moving averages (SMA) of 21.06 and 20.68, respectively. However, it remains slightly above its 200-day SMA of 19.64, indicating some longer-term support. The Average True Range (ATR) of 0.35 suggests relatively low volatility, while the average 20-day volume of 2355 shares highlights limited liquidity. The funds assets under management (AUM) of $8.20 million reflect its niche focus and smaller market presence.
Over the next three months, FDHT is expected to remain range-bound, with potential resistance near its 20-day SMA of 21.06 and support at its 200-day SMA of 19.64. The low average volume and tight ATR suggest that price movements may be muted, with limited upside or downside momentum. Fundamental tailwinds from the growing adoption of digital health solutions could provide moderate support, but the funds small AUM and concentration in a specialized sector may limit its near-term growth.
Additional Sources for FDHT ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FDHT ETF Overview
Market Cap in USD | 8m |
Category | Health |
TER | 0.39% |
IPO / Inception | 2021-10-05 |
FDHT ETF Ratings
Growth 5y | -3.61% |
Fundamental | - |
Dividend | 35.7% |
Rel. Strength Industry | -6.36 |
Analysts | - |
Fair Price Momentum | 17.55 USD |
Fair Price DCF | - |
FDHT Dividends
Dividend Yield 12m | 1.54% |
Yield on Cost 5y | 1.20% |
Annual Growth 5y | 135.13% |
Payout Consistency | 58.3% |
FDHT Growth Ratios
Growth Correlation 3m | 38.9% |
Growth Correlation 12m | 81.2% |
Growth Correlation 5y | -22.1% |
CAGR 5y | -6.90% |
CAGR/Max DD 5y | -0.15 |
Sharpe Ratio 12m | 1.00 |
Alpha | -5.97 |
Beta | 0.81 |
Volatility | 20.94% |
Current Volume | 1.6k |
Average Volume 20d | 2.3k |
As of March 14, 2025, the stock is trading at USD 19.59 with a total of 1,623 shares traded.
Over the past week, the price has changed by -4.70%, over one month by -8.46%, over three months by -4.07% and over the past year by +2.57%.
Neither. Based on ValueRay Analyses, Fidelity Covington Trust - is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -3.61 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FDHT as of March 2025 is 17.55. This means that FDHT is currently overvalued and has a potential downside of -10.41%.
Fidelity Covington Trust - has no consensus analysts rating.
According to ValueRays Forecast Model, FDHT Fidelity Covington Trust - will be worth about 19.6 in March 2026. The stock is currently trading at 19.59. This means that the stock has a potential upside of +0.1%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 19.6 | 0.1% |